Track MLTX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
MLTX - MoonLake Immunotherapeutics (MLTX) has a earnings per share of -$0.98, down 55.6% over the past year.
Latest EPS (Actual)
-$0.98
Beat Rate
25.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.92 | -$0.98 | Miss | -6.37% |
| Feb 2026 | -$0.98 | -$0.92 | Beat | +6.05% |
| Nov 2025 | -$0.89 | -$1.10 | Miss | -23.60% |
| Aug 2025 | -$0.72 | -$0.87 | Miss | -20.83% |
| May 2025 | -$0.74 | -$0.63 | Beat | +14.34% |
| Feb 2025 | -$0.59 | -$0.72 | Miss | -21.46% |
| Nov 2024 | -$0.44 | -$0.56 | Miss | -27.27% |
| Aug 2024 | -$0.28 | -$0.39 | Miss | -39.29% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.